Takeover

NGVTIngevity Corp

Chemicals & Allied Products

Revenue
$1.2BFY2021: $1.4BFY2022: $1.7BFY2023: $1.2BFY2024: $1.2BFY2025: $1.2B
2.7% YoY
Operating margin
35.9%FY2021: 30.3%FY2022: 27.1%FY2023: 34.8%FY2024: 35.5%FY2025: 35.9%
1.0% YoY
EBITDA
$525MFY2021: $532MFY2022: $561MFY2023: $546MFY2024: $534MFY2025: $525M
1.7% YoY
Market cap
$2.6B
Employees
1,500
$778K revenue each
Net debt / EBITDA
2.3×
$1.2B net debt
AI in 10-K
0.9
mentions per 10K words

Takeover score 1 of 13

Fixable underperformance 0 of 7

Buyer economics 1 of 4

Catalysts 0 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$1.4B$1.7B$1.2B$1.2B$1.2B 2.7% FY2021: $1.4BFY2022: $1.7BFY2023: $1.2BFY2024: $1.2BFY2025: $1.2B
Operating income$422M$453M$423M$426M$419M 1.7% FY2021: $422MFY2022: $453MFY2023: $423MFY2024: $426MFY2025: $419M
Net income$118M$212M−$5M−$430M−$167M 61% FY2021: $118MFY2022: $212MFY2023: −$5MFY2024: −$430MFY2025: −$167M
Operating cash flow$293M$313M$205M$129M$331M 158% FY2021: $293MFY2022: $313MFY2023: $205MFY2024: $129MFY2025: $331M
Capex$104M$143M$110M$78M$58M 26% FY2021: $104MFY2022: $143MFY2023: $110MFY2024: $78MFY2025: $58M
Stock-based comp$12M$16M$11M$12M$18M 54% FY2021: $12MFY2022: $16MFY2023: $11MFY2024: $12MFY2025: $18M
Buybacks$109M$145M$92M$0$56MFY2021: $109MFY2022: $145MFY2023: $92MFY2024: $0FY2025: $56M

Deal filings

None.

13D filers

FiledFilerFormStakeIntent
Feb 28, 2024INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D/A3.2%Active
May 30, 2023INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D/A6.6%Active
Jul 27, 2022INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D/A5.6%Active
Apr 7, 2022INCLUSIVE CAPITAL PARTNERS, L.P.SC 13D10.8%Active

Insider trading

Open-market buys, 12 mo
$0 · 0
Open-market sells, 12 mo
$2M · 10
Net
−$2M

Pay vs performance

No pay-versus-performance disclosure yet.